193 related articles for article (PubMed ID: 37068406)
1. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
Tichanek F; Försti A; Hemminki A; Hemminki O; Hemminki K
Eur J Cancer; 2023 Jun; 186():133-141. PubMed ID: 37068406
[TBL] [Abstract][Full Text] [Related]
2. Conditional survival in breast cancer up to 10 years in the Nordic countries.
Zitricky F; Försti A; Hemminki A; Hemminki K
Cancer Med; 2023 Sep; 12(17):17945-17951. PubMed ID: 37578395
[TBL] [Abstract][Full Text] [Related]
3. Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies.
Lundberg FE; Birgisson H; Engholm G; Ólafsdóttir EJ; Mørch LS; Johannesen TB; Pettersson D; Lambe M; Seppä K; Lambert PC; Johansson ALV; Hölmich LR; Andersson TM
Eur J Cancer; 2024 May; 202():113980. PubMed ID: 38452724
[TBL] [Abstract][Full Text] [Related]
4. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
5. Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies.
Lundberg FE; Kroman N; Lambe M; Andersson TM; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Lambert PC; Mørch LS; Johansson ALV
Acta Oncol; 2022 Dec; 61(12):1481-1489. PubMed ID: 36542678
[TBL] [Abstract][Full Text] [Related]
6. Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.
Tichanek F; Försti A; Hemminki O; Hemminki A; Hemminki K
Cancer Epidemiol; 2023 Sep; ():102449. PubMed ID: 37679266
[TBL] [Abstract][Full Text] [Related]
7. Survival trends in solid cancers in the Nordic countries through 50 years.
Hemminki J; Försti A; Hemminki A; Hemminki K
Eur J Cancer; 2022 Nov; 175():77-85. PubMed ID: 36096040
[TBL] [Abstract][Full Text] [Related]
8. Major improvement in thyroid cancer survival of elderly patients in the Nordic countries.
Zitrický F; Koskinen A; Liska V; Försti A; Hemminki A; Hemminki K
Eur J Endocrinol; 2024 Mar; 190(3):K32-K36. PubMed ID: 38436478
[TBL] [Abstract][Full Text] [Related]
9. Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.
Karttunen E; Hervonen P; Hosseini Aliabad A; Oldenburg J; Pappot H; Sairanen J; Støvring H; Vásquez JL; Bergman S; Magnussen G; Norremark P; Thoresen S; Ullén A
Scand J Urol; 2023; 57(1-6):15-21. PubMed ID: 36416403
[TBL] [Abstract][Full Text] [Related]
10. Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.
Hemminki K; Försti A; Hemminki O; Liska V; Hemminki A
Int J Cancer; 2022 Jul; 151(2):200-208. PubMed ID: 35213036
[TBL] [Abstract][Full Text] [Related]
11. Survival in gastric and esophageal cancers in the Nordic countries through a half century.
Hemminki K; Tichanek F; Försti A; Hemminki O; Hemminki A
Cancer Med; 2023 May; 12(9):10212-10221. PubMed ID: 36846972
[TBL] [Abstract][Full Text] [Related]
12. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.
Lundberg FE; Andersson TM; Lambe M; Engholm G; Mørch LS; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Johansson ALV; Lambert PC
Acta Oncol; 2020 Nov; 59(11):1266-1274. PubMed ID: 33073632
[TBL] [Abstract][Full Text] [Related]
13. Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
Hemminki K; Kanerva A; Försti A; Hemminki A
BMC Cancer; 2022 Apr; 22(1):456. PubMed ID: 35473606
[TBL] [Abstract][Full Text] [Related]
14. Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century.
Tichanek F; Försti A; Liska V; Hemminki A; Hemminki K
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765946
[No Abstract] [Full Text] [Related]
15. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Bray F; Klint A; Hakulinen T; Storm HH; Engholm G
Acta Oncol; 2010 Jun; 49(5):624-31. PubMed ID: 20429724
[TBL] [Abstract][Full Text] [Related]
16. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
[TBL] [Abstract][Full Text] [Related]
17. Early mortality critically impedes improvements in thyroid cancer survival through a half century.
Tichanek F; Försti A; Liska V; Hemminki O; Koskinen A; Hemminki A; Hemminki K
Eur J Endocrinol; 2023 Sep; 189(3):355-362. PubMed ID: 37675794
[TBL] [Abstract][Full Text] [Related]
18. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.
Hemminki K; Försti A; Chen T; Hemminki A
BMC Cancer; 2021 Nov; 21(1):1189. PubMed ID: 34749677
[TBL] [Abstract][Full Text] [Related]
19. Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era.
Wood K; Luke JJ
Curr Oncol Rep; 2016 Nov; 18(11):67. PubMed ID: 27613168
[TBL] [Abstract][Full Text] [Related]
20. Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive.
Ghate S; Ionescu-Ittu R; Burne R; Ndife B; Laliberté F; Nakasato A; Duh MS
Melanoma Res; 2019 Jun; 29(3):301-310. PubMed ID: 30247203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
